Rare POLE P286R-Mutated Lung Cancer Shows Dramatic Response to Immunotherapy
A case report describes the first hepatoid adenocarcinoma of the lung harboring a POLE P286R mutation, which drove hypermutation, mismatch ...
Tag: Immunotherapy
Immunotherapy Plus Chemoradiotherapy Triples Survival in Esophageal Cancer Study
A propensity score matched study from Taiwan finds that adding the immunotherapy drug nivolumab to definitive chemoradiotherapy tripled median overall ...
Two Proteins Found on Nearly All Liver Cancer Cells Point to a Dual-Target CAR-T Strategy
A study of 140 liver tumor samples shows that Glypican-3 and AXL are co-expressed in nearly all hepatocellular carcinomas, supporting ...
Transparent AI Model Hits 95% Accuracy in Choosing Immunotherapy for Head and Neck Cancer
Researchers in Leipzig corrected a hidden error in a Bayesian network and found the transparent AI model matched real tumor ...
Immune Receptor FcγRIIb Emerges as Gatekeeper of Parkinson’s Protein Spread
New research shows that deleting or blocking the immune receptor FcγRIIb dramatically impairs the spread of alpha-synuclein pathology in the ...
Stents Plus Neoadjuvant Therapy Reshapes Outcomes in Obstructive Colorectal Cancer
A multicenter retrospective study of 154 patients finds that combining self-expandable metal stents with modern neoadjuvant therapy reduces stomas and ...
AI-Guided Modeling Uncovers Hidden Switches That Could Heat Up Cold Pancreatic Tumors
Researchers at Eindhoven University of Technology combined active learning with mechanistic logic-ODE models to uncover context-specific regulators of the immune-recruiting ...
AI Reads Routine CT Scans to Predict Dangerous Immunotherapy Lung Inflammation Before It Starts
A deep learning model from MD Anderson analyzes routine pretreatment chest CT scans to predict which lung cancer patients will ...
Small Triple-Negative Breast Tumors Blur the Line Between Stage I and Stage II Treatment
A retrospective cohort study of 215 patients finds that small node-negative triple-negative breast cancers show similar biology and outcomes across ...
Surufatinib Plus Immunotherapy Shows Promise as Maintenance Therapy for Aggressive Lung Cancer
A phase 2a trial found that surufatinib combined with PD-1/PD-L1 inhibitors as first-line maintenance therapy yielded a median progression-free survival ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!